Recruiting

Observational Study

Sponsor:

Stanford University

Code:

NCT04330521

Conditions

Cancer

COVID-19

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of this study is to understand the impact of COVID-19 on patients with cancer through a survey.

Conditions

Cancer

COVID-19

Study ID

NCT04330521

Start date

Apr 8, 2020

Status verified date

Apr, 2026

Completion date

Dec, 2027

Anticipated

Primary completion date

Dec, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. The patients must be 18 years or older.
2. Patients who opt in to complete the survey.
3. Patients must have the capacity to verbally consent for the interview.

Exclusion Criteria:

1.Patients who under the age of 18 years old.

Study Design

Enrollment

50 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Number of participants who fill out the survey and participate in the semi-structured interviews. [ Time Frame: 12 Months ]

Central Contacts and Locations

Locations

Stanford University School of Medicine

Recruiting

Stanford, California, United States, 94305

Contacts

Manali I Patel, MD MPH MS

650-723-4000manalip@stanford.edu

Principal Investigator:

Manali I Patel, MD MPH MS

More Information

Sponsor

Stanford University

Last update posted

Apr 27, 2026

Last verified

Apr, 2026

Keywords

  • Coronavirus
  • COVID-19
  • Cancer
  • Life Change Events

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Stanford University on 2026-04-27.